Pacer Advisors
ANAB icon

Pacer Advisors’s AnaptysBio ANAB Stock Holding History

Pacer Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25K Buy
+365
New +$22.1K ﹤0.01% 2210
2024
Q3 		– Sell
-283
Closed -$7.09K – 2566
2024
Q2 		$7.09K Sell
283
-139
-33% -$3.24K ﹤0.01% 3601
2024
Q1 		$9.5K Buy
+422
New +$9.99K ﹤0.01% 3541
2021
Q2 		– Sell
-2,122
Closed -$46K – 1413
2021
Q1 		$46K Buy
2,122
+510
+32% +$12.9K ﹤0.01% 1445
2020
Q4 		$35K Sell
1,612
-250
-13% -$6.07K ﹤0.01% 1446
2020
Q3 		$27K Buy
+1,862
New +$33.6K ﹤0.01% 1343
2018
Q4 		– Sell
-3,699
Closed -$369K – 556
2018
Q3 		$369K Buy
+3,699
New +$307K 0.01% 915

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Pacer Advisors's ANAB Position: Q2 2026 in Review

Pacer Advisors opened a new position in AnaptysBio (ANAB) in Q2 2026: 365 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #2210 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in ANAB as recently as Q2 2024.

Pacer Advisors first reported a position in ANAB in Q3 2018 and has held it in 7 quarters since. The position peaked at $369K in Q3 2018. 214 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Pacer Advisors held 365 shares of AnaptysBio worth $25K as of Q2 2026.
  • AnaptysBio was a new Pacer Advisors position in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2210 holding.
  • Pacer Advisors first reported a position in AnaptysBio in Q3 2018 and has held it in 7 quarters since.
  • Pacer Advisors's AnaptysBio position peaked at $369K in Q3 2018.
  • 214 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.